Navicixizumab, CAS [[1638338-43-8]]

Produktübersicht

• Artikelname: Navicixizumab, CAS [[1638338-43-8]]
• Artikelnummer: MCE-HY-P99377
• Hersteller Artikelnummer: HY-P99377
• Alternativnummer: MCE-HY-P99377-10MG,MCE-HY-P99377-1MG,MCE-HY-P99377-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: OMP-305B83, Anti-DLL4 Reference Antibody (navicixizumab)

Produktbeschreibung

Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer[1][2][3].

Produkteigenschaften

• Molekulargewicht: (145.83 kDa)
• Reinheit: 99.83
• CAS Nummer: [1638338-43-8]
• Target-Kategorie: Notch

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies